RxSight specializes in innovative ophthalmic technologies, particularly focusing on the Light Adjustable Lens™ (LAL™/LAL+™). This groundbreaking lens is unique in that it allows for customization even after cataract surgery, providing patients with a tailored visual experience. The LAL™ technology utilizes a proprietary light delivery system that enables healthcare professionals to adjust the lens power post-operatively, ensuring optimal vision correction based on individual patient needs.

In addition to the LAL™, RxSight is actively developing a pipeline of products aimed at enhancing visual outcomes for patients undergoing cataract surgery. The company's commitment to advancing ophthalmic care is evident in its focus on scientific research and technological innovation, which seeks to improve the overall quality of life for patients by providing customizable and effective solutions for vision correction.

United States

RxSight® is an ophthalmic medical technology corporation headquartered in Aliso Viejo, California that has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery. The company’s mission is to revolutionize the premium cataract surgery experience by allowing surgeons to partner with their patients to achieve optimized results for every unique eye.


RxSight

Company Details